Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A.
American National Red Cross, Washington, DC, United States
Search 3 grants from Todd Hembrough
Search grants from American National Red Cross
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Post-Doctoral Training in Intellectual and Developmental Disabilities Research
MicroRNAs in African American Prostate Cancer
Early Childhood Perception, Cognitive Control and Neural Correlates
Kansas Youth Suicide Prevention: Collaboration and Service Across our State
The Molecular Basis of IA Heterodimer Formation
Recently added grants:
Developmental Funds
Planning and Evaluation
Clinical Protocoal and Data Management
Protocol Review and Monitoring System
Shared Resource Management
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32HL009910-02
Application #
2838876
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1998-12-01
Project End
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Related projects
NIH 2000
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
$21,616
NIH 1999
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
NIH 1998
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
Publications
Hembrough, T A; Ruiz, J F; Papathanassiu, A E et al.
(2001)
Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor.
J Biol Chem 276:12241-8
Comments
Be the first to comment on Todd Hembrough's grant